These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12520151)

  • 21. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Withdrawal-emergent dyskinesia in a patient taking risperidone/citalopram.
    Miller LJ
    Ann Pharmacother; 2000 Feb; 34(2):269. PubMed ID: 10676841
    [No Abstract]   [Full Text] [Related]  

  • 23. Clozapine and venous thromboembolism: further evidence.
    Selten JP; Büller H
    J Clin Psychiatry; 2003 May; 64(5):609. PubMed ID: 12755667
    [No Abstract]   [Full Text] [Related]  

  • 24. Olanzapine and venous thromboembolism.
    Hägg S; Tätting P; Spigset O
    Int Clin Psychopharmacol; 2003 Sep; 18(5):299-300. PubMed ID: 12920392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antipsychotic drugs and risk of venous thromboembolism: nested case-control study.
    Parker C; Coupland C; Hippisley-Cox J
    BMJ; 2010 Sep; 341():c4245. PubMed ID: 20858909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risks of thromboembolism associated with hormone contraceptives in Japanese compared with Western women.
    Kobayashi T; Sugiura K; Ojima T
    J Obstet Gynaecol Res; 2017 May; 43(5):789-797. PubMed ID: 28422361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Specific treatments of the psychiatric community and thrombogenesis].
    Khammassi N; Chrifi J; Hamza M; Cherif O
    Encephale; 2013 Apr; 39(2):143-8. PubMed ID: 23095579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence and predictors of acute akathisia in severely ill patients with first-episode schizophrenia treated with aripiprazole or risperidone: secondary analysis of an observational study.
    Yoshimura B; Sato K; Sakamoto S; Tsukahara M; Yoshimura Y; So R
    Psychopharmacology (Berl); 2019 Feb; 236(2):723-730. PubMed ID: 30443794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risperidone-induced Pisa syndrome in MS: resolution with lurasidone and recurrence with Chlorpromazine.
    Iuppa CA; Diefenderfer LA
    Ann Pharmacother; 2013 Sep; 47(9):1223-8. PubMed ID: 24259741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolactin serum levels in paranoid versus nonparanoid male schizophrenia patients treated with risperidone.
    Segal M; Avital A; Derevenski A; Berstein S; Sandbank S; Weizman A
    Int Clin Psychopharmacol; 2007 Jul; 22(4):192-6. PubMed ID: 17519641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antipsychotic and antidepressant drug use in the elderly and the risk of venous thromboembolism.
    Ray JG; Mamdani MM; Yeo EL
    Thromb Haemost; 2002 Aug; 88(2):205-9. PubMed ID: 12195690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tolerability and safety profile of risperidone in a sample of children and adolescents.
    Margari L; Matera E; Craig F; Petruzzelli MG; Palmieri VO; Pastore A; Margari F
    Int Clin Psychopharmacol; 2013 Jul; 28(4):177-83. PubMed ID: 23689836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of neuropsychological effects of adjunctive risperidone or quetiapine in euthymic patients with bipolar I disorder.
    Kozicky JM; Torres IJ; Bond DJ; Lam RW; Yatham LN
    Int Clin Psychopharmacol; 2012 Mar; 27(2):91-9. PubMed ID: 22124206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hyperprolactinemia induced by neuroleptics].
    Lakartidningen; 2007 May 9-15; 104(19):1522. PubMed ID: 17550031
    [No Abstract]   [Full Text] [Related]  

  • 35. Antipsychotic-induced extrapyramidal syndromes. Risperidone compared with low- and high-potency conventional antipsychotic drugs.
    Schillevoort I; de Boer A; Herings RM; Roos RA; Jansen PA; Leufkens HG
    Eur J Clin Pharmacol; 2001 Jul; 57(4):327-31. PubMed ID: 11549212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel versus conventional antipsychotic drugs.
    Love RC
    Pharmacotherapy; 1996; 16(1 Pt 2):6-10. PubMed ID: 8778684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of risperidone versus olanzapine in patients with schizophrenia previously on chronic conventional antipsychotic therapy: a switch study.
    Wang X; Savage R; Borisov A; Rosenberg J; Woolwine B; Tucker M; May R; Feldman J; Nemeroff CB; Miller AH
    J Psychiatr Res; 2006 Oct; 40(7):669-76. PubMed ID: 16762371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A cross-sectional study of plasma risperidone levels with risperidone long-acting injectable: implications for dopamine D2 receptor occupancy during maintenance treatment in schizophrenia.
    Ikai S; Remington G; Suzuki T; Takeuchi H; Tsuboi T; Den R; Hirano J; Tsunoda K; Nishimoto M; Watanabe K; Mimura M; Mamo D; Uchida H
    J Clin Psychiatry; 2012 Aug; 73(8):1147-52. PubMed ID: 22967779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antipsychotic medication dispensing and associated odds ratios of death in elderly veterans and war widows, 2001.
    Hollis J; Touyz S; Grayson D; Forrester L
    Aust N Z J Psychiatry; 2006; 40(11-12):981-6. PubMed ID: 17054566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.